Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
5,880.00    -145.00 (-2.41%)
Bid:
5,880.00
Ask:
6,100.00
Spread: 220.00 (3.741%)
Market Cap: £5.15b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Board Changes

9 Nov 2021 07:00

RNS Number : 7218R
DCC PLC
09 November 2021
 

 

9 November 2021

Board Changes

 

Appointment of New Non-Executive Director

DCC plc, the leading international sales, marketing and support services group, announces the appointment of Mr. Alan Ralph as a non-executive Director and member of the Audit Committee with effect from 8 November 2021.

Mr. Ralph is a very experienced business and finance leader having spent almost 20 years with UDG Healthcare plc (formerly United Drug plc). Mr. Ralph spent ten years leading UDG's largest business unit before supporting its strategic transformation as Chief Financial Officer for five years. Mr. Ralph is a Chartered Accountant.

There are no details to be disclosed under Listing Rule 9.6.13 in respect of Mr. Ralph.

Appointment of Workforce Engagement Director

Mr. Mark Ryan, who has been a non-executive Director since November 2017, has been appointed as the designated Director for engagement with the workforce, succeeding Mr. Cormac McCarthy who passed away in July 2021. Mr. Ryan has also been appointed as a member of the Governance and Sustainability Committee. Both appointments take effect from 8 November 2021.

Mark Breuer, Chairman of DCC plc, said:

"I warmly welcome Alan Ralph to the Board. His financial expertise, business leadership experience and knowledge of the healthcare sector will enhance the Board's knowledge in several key areas."

"I am also very pleased that Mark Ryan will take on the important role of workforce engagement Director. Mark has been a valued member of the Board since 2017 and will bring his knowledge of DCC and extensive business experience to the position."

Contact information 

Investor enquiries:

Darragh Byrne, Company Secretary

Rossa White, Head of Group Investor Relations

Tel: +353 1 2799 400

Email: investorrelations@dcc.ie

 

 

Media enquiries:

Powerscourt (Eavan Gannon/Victoria Palmer Moore)

Tel: +44 20 7250 1446

Email: DCC@powerscourt-group.com

 

 

DCC website:

www.dcc.ie

 

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Healthcare and Technology. DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2021, DCC generated revenue of £13.4 billion and operating profit of £530.2 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABPBLTMTTMBMB
Date   Source Headline
8th Jul 20226:11 pmRNSHolding in Company - TR1
30th Jun 20222:59 pmRNSAppointment of Chief Executive Officer, DCC Energy
16th Jun 202210:20 amRNS2022 Annual Report, Notice of AGM and Proxy Form
31st May 20221:19 pmRNSTotal Voting Rights
30th May 20229:00 amRNSDirector/PDMR Shareholding
26th May 20225:41 pmRNSDirector/PDMR Shareholding
17th May 20227:00 amRNSDCC plc Investor Event Today - Leading with Energy
17th May 20227:00 amRNSResults for the year ended 31 March 2022
7th Apr 20227:00 amRNSDCC plc Upcoming Events
28th Feb 202210:44 amRNSTotal Voting Rights
15th Feb 20227:00 amRNSDCC Technology Presentation and Webcast
8th Feb 20227:00 amRNSBoard Changes
8th Feb 20227:00 amRNSInterim Management Statement
3rd Feb 202211:54 amRNSDCC Technology Presentation and Webcast
15th Dec 20217:00 amRNSDCC Management Presentation
15th Dec 20217:00 amRNSDCC plc acquires Almo Corporation
30th Nov 20214:31 pmRNSTotal Voting Rights
26th Nov 20217:15 amRNSDirector Declaration
15th Nov 20214:25 pmRNSDirector/PDMR Shareholding
11th Nov 20214:58 pmRNSDirector/PDMR Shareholding
11th Nov 202111:25 amRNSDirector/PDMR Shareholding
9th Nov 202110:01 amRNSUpdate on Timing of Interim Results Announcement
9th Nov 20217:00 amRNSBoard Changes
9th Nov 20217:00 amRNSResults for the six months ended 30 September 2021
28th Sep 20217:00 amRNSDCC Healthcare Event
14th Sep 20212:33 pmRNSDCC Healthcare Event
16th Jul 20212:17 pmRNSResult of AGM
16th Jul 20217:00 amRNSBoard Changes
16th Jul 20217:00 amRNSInterim Management Statement
13th Jul 20217:10 amRNS2021 Sustainability Report
7th Jul 20217:01 amRNSMr Cormac McCarthy
17th Jun 202112:34 pmRNS2021 Annual Report, Notice of AGM and Proxy Form
1st Jun 20217:00 amRNSTotal Voting Rights
27th May 20215:47 pmRNSDirector/PDMR Shareholding
20th May 20219:45 amRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSAppointment of Chairman Designate & Board Renewal
18th May 20217:00 amRNSResults for the year ended 31 March 2021
23rd Apr 20217:14 amRNSDirector Declaration
1st Apr 20217:13 amRNSDirector Declaration
23rd Mar 20217:06 amRNSDirector Declaration
15th Mar 20217:00 amRNSDCC Healthcare acquires primary care supplier
11th Mar 20219:12 amRNSUpdate on the Migration to Euroclear Bank
26th Feb 202112:26 pmRNSTotal Voting Rights
18th Feb 20212:12 pmRNSDCC Consents to Migration of Ordinary Shares
11th Feb 20215:02 pmRNSDirector/PDMR Shareholding
4th Feb 20215:01 pmRNSDirector/PDMR Shareholding
4th Feb 20211:46 pmRNSResult of EGM
2nd Feb 20217:00 amRNSInterim Management Statement
26th Jan 20217:43 amRNSDirector Declaration
7th Jan 20214:55 pmRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.